The deliverable

A sample Practice X-Ray.

This is the document a practice receives — the number, the channel call per drug and payer, the re-billable money found in the claims, and the graded audit. It’s built from an illustrative example practice, not a real customer’s data, so you can see the shape of what you’d get.

EXAMPLE — ILLUSTRATIVE DATA

Practice X-Ray

Rheumatology Associates of Delmarva (example)

5 physicians · commercial + Medicare book

$2.70M/yr

realistic year-one margin opportunity — Medicare measured, commercial modeled, cut down from $9.26M identified through the rules ledger.

1 · The channel call, per drug

The winning channel isn’t the same twice — billed the default way, the biggest drugs leak.

Drug	Buy & bill	In-house	Winner	Δ / dose
Entyvio J3380	$923	$3,719	in-house	+$2,796
Infliximab J1745	$355	$3,049	in-house	+$2,694
Prolia J0897	$668	$263	buy-and-bill	+$405

2 · Money you can recover now

Re-billable claims found in the remittances — per-claim math your team verifies in your own PM system.

J1745 Infliximab · DOS 2025-09 · paid $29.50 vs $31.48 limit

+$1,900 recoverable

3 · The graded audit — five places margin leaks

Payment integrityEvery Medicare line graded against its quarter's payment limit — underpaid, wrong-quarter, units-mismatch.

$214K

White-bag signatureAdmin fee billed, no drug margin — fills routed away from the practice.

$96K

Denial dragTop denial reasons by payer & drug; what each write-off costs to earn back.

$61K

Payment latencyDays-to-pay by payer, turned into carrying cost on every add-on.

$28K

RecoupmentsWhat's clawed back after payment, and why.

$19K

Figures illustrative. Every line in a real X-Ray traces to your own claims plus sourced public data (CMS ASP, NADAC), with every deduction citing its rule — see the methodology.

See this on your own book.

Get your free Practice X-Ray

Starts with your NPI — public data, nothing to send. See what activation looks like.

Loading…